ArticleBlood advances2021

Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.

Giulia Pavani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.